Market Overview

S-1 from Aclaris Therapeutics Shows Registration for $86.25M IPO

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News IPOs

 

Related Articles (ACRS)